Zobrazeno 1 - 10
of 123
pro vyhledávání: '"Jellema, K."'
Publikováno v:
In Disability and Health Journal July 2024 17(3)
Autor:
Bijlsma, M.W., Citroen, J., van Geel, B.M., Groeneveld, N.S., Heckenberg, S.G.B., Jellema, K., Kester, M.I., Killestein, J., Mook, B.B., Resok, Y.C., Olie, S.E., Staal, S.L., Titulaer, M.J., van Veen, K.E.B., van Zeggeren, I.E., Pennartz, C.J., ter Horst, L., van de Beek, D., Brouwer, M.C.
Publikováno v:
In Journal of Hospital Infection March 2024 145:99-105
Autor:
ter Horst, Liora, van Zeggeren, Ingeborg E., Olie, Sabine E., Brenner, J., Citroen, J., van Geel, B.M., Heckenberg, S.G.B., Jellema, K., Kester, M.I., Killestein, J., Mook, B.B., Resok, Y.C., Titulaer, M.J., van Veen, K.E.B., Verschuur, C.V.M., van de Beek, Diederik, Brouwer, Matthijs C.
Publikováno v:
Scientific Reports; 12/1/2023, Vol. 13 Issue 1, p1-10, 10p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Holl, D.C., Blaauw, J., Ista, E., Dirven, C.M.F., Kho, K.H., Jellema, K., Gaag, N.A. van der, Miah, I.P., Hertog, H.M. den, Naalt, J. van der, Jacobs, B., Verbaan, D., Polinder, S., Lingsma, H.F., Dammers, R., Dutch Subdural Hematoma Res Grp Co
Publikováno v:
Brain and Behavior, 12(3). Wiley-Blackwell
Brain and behavior, 12(3):e2463. John Wiley and Sons Inc.
Brain and Behavior, 12(3):e2463. John Wiley & Sons Inc.
Brain and Behavior, 12(3). WILEY
Brain and behavior, 12(3):e2463. John Wiley and Sons Inc.
Brain and Behavior, 12(3):e2463. John Wiley & Sons Inc.
Brain and Behavior, 12(3). WILEY
BACKGROUND: Chronic subdural hematoma (CSDH) is a frequent pathological entity in daily clinical practice. However, evidence-based CSDH-guidelines are lacking and level I evidence from randomized clinical trials (RCTs) is limited. In order to establi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c976cdbe2ce4eb41a7af0fa805532421
https://hdl.handle.net/1887/3276387
https://hdl.handle.net/1887/3276387
Autor:
Olie, Sabine E., van Zeggeren, Ingeborg E., ter Horst, Liora, I.-PACE Study Group, Citroen, J., van Geel, B. M., Heckenberg, S. G. B., Jellema, K., Kester, M. I., Killestein, J., Mook, B. B., Titulaer, M. J., van Veen, K. E. B., Verschuur, C. V. M., van de Beek, Diederik, Brouwer, Matthijs C.
Publikováno v:
BMC Neurology; 11/14/2022, Vol. 22 Issue 1, p1-9, 9p
Autor:
Jacobs, B, van den Berg, B, Verboon, C, Chavada, G, Cornblath, D, Gorson, K, Harbo, T, Hartung, H, Hughes, R, Kusunoki, S, van Doorn, P, Willison, H, Consortium, I, van Woerkom, M, Roodbol, J, Reisin, R, Reddel, S, Islam, Z, Islam, B, Mohammad, Q, van den Bergh, P, Feasby, T, Wang, Y, Péréon, Y, Lehmann, H, Dardiotis, E, Nobile Orazio, E, Shahrizaila, N, Bateman, K, Illa, I, Querol, L, Hsieh, S, Davidson, A, Addington, J, Ajroud Driss, S, Andersen, H, Antonini, G, Attarian, S, Badrising, U, Barroso, F, Benedetti, L, Beronio, A, Bianco, M, Binda, D, Briani, C, Bürmann, J, Bella, I, Bertorini, T, Bhavaraju Sanka, R, Brannagan, T, Busby, M, Butterworth, S, Campagnolo, M, Casasnovas, C, Cavaletti, G, Chao, C, Chen, S, Chetty, S, Claeys, K, Cohen, J, Conti, M, Cosgrove, J, Dalakas, M, Dimachkie, M, Dillmann, U, Domínguez González, C, Doppler, K, Dornonville de la Cour, C, Echaniz Laguna, A, Eftimov, F, Faber, C, Fazio, R, Fokke, C, Fujioka, T, Fulgenzi, E, Galassi, G, Garcia, T, Garnero, M, Garssen, M, Gijsbers, C, Gilchrist, J, Gilhuis, H, Goldstein, J, Goyal, N, Granit, V, Grapperon, A, Gutiérrez Gutiérrez, G, Gutmann, L, Hadden, R, Holbech, J, Holt, J, Homedes Pedret, C, Htut, M, Jellema, K, Jericó Pascual, I, Kaida, K, Karafiath, S, Katzberg, H, Kiers, L, Kieseier, B, Kimpinski, K, Kleyweg, R, Kokubun, N, Kolb, N, Kuitwaard, K, Kuwabara, S, Kwan, J, Ladha, S, Landschoff Lassen, L, Lawson, V, Ledingham, D, Léon Cejas, L, Luciano, C, Lucy, S, Lunn, M, Magot, A, Manji, H, Marchesoni, C, Marfia, Ga, Márquez Infante, C, Martinez Hernandez, E, Mataluni, G, Mattiazi, M, Mcdermott, C, Meekins, G, Miller, J, Monges, M, Montero, M, Morís de la Tassa, G, Nascimbene, C, Neumann, C, Nowak, R, Orizaola Balaguer, P, Osei Bonsu, M, Pan, E, Pardo Fernandez, J, Pasnoor, M, Pulley, M, Rajabally, Y, Rinaldi, S, Ritter, C, Roberts, R, Rojas Marcos, I, Rudnicki, S, Sachs, G, Samijn, J, Santoro, L, Saperstein, D, Savransky, A, Schneider, H, Schenone, A, Sedano Tous, M, Sekiguchi, Y, Sheikh, K, Silvestri, N, Sindrup, S, Sommer, C, Stein, B, Stino, A, Spyropoulos, A, Srinivasan, J, Suzuki, H, Taylor, S, Tankisi, H, Tigner, D, Twydell, P, Valzania, F, van Damme, P, van der Kooi, A, van Dijk, G, van der Ree, T, van Koningsveld, R, Varrato, J, Vermeij, F, Verschuuren, J, Visser, L, Vytopil, M, Waheed, W, Wilken, M, Wilkerson, C, Wirtz, P, Yamagishi, Y, Yiu, E, Zhou, L, Zivkovic, S
Publikováno v:
Jacobs, B C, van den Berg, B, Verboon, C, Chavada, G, Cornblath, D R, Gorson, K C, Harbo, T, Hartung, H-P, Hughes, R A C, Kusunoki, S, van Doorn, P A, Willison, H J & IGOS Consortium 2017, ' International Guillain-Barre Syndrome Outcome Study : protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barre syndrome ', Journal of the Peripheral Nervous System, vol. 22, no. 2, pp. 68-76 . https://doi.org/10.1111/jns.12209
Jacobs, B C, van den Berg, B, Verboon, C, Chavada, G, Cornblath, D R, Gorson, K C, Harbo, T, Hartung, H P, Hughes, R A C, Kusunoki, S, van Doorn, P A, Willison, H J & the IGOS Consortium 2017, ' International Guillain-Barré Syndrome Outcome Study : protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome ', Journal of the Peripheral Nervous System, vol. 22, no. 2, pp. 68-76 . https://doi.org/10.1111/jns.12209
Journal of the Peripheral Nervous System, 22(2), 68-76. Wiley-Blackwell Publishing Ltd
Journal of the Peripheral Nervous System, 22(2), 68-76. Wiley-Blackwell
Journal of the peripheral nervous system, 22(2), 68-76. Wiley-Blackwell
Journal of the Peripheral Nervous System, 22(2), 68-76
Jacobs, B C, van den Berg, B, Verboon, C, Chavada, G, Cornblath, D R, Gorson, K C, Harbo, T, Hartung, H P, Hughes, R A C, Kusunoki, S, van Doorn, P A, Willison, H J & the IGOS Consortium 2017, ' International Guillain-Barré Syndrome Outcome Study : protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome ', Journal of the Peripheral Nervous System, vol. 22, no. 2, pp. 68-76 . https://doi.org/10.1111/jns.12209
Journal of the Peripheral Nervous System, 22(2), 68-76. Wiley-Blackwell Publishing Ltd
Journal of the Peripheral Nervous System, 22(2), 68-76. Wiley-Blackwell
Journal of the peripheral nervous system, 22(2), 68-76. Wiley-Blackwell
Journal of the Peripheral Nervous System, 22(2), 68-76
Guillain-Barré syndrome (GBS) is an acute polyradiculoneuropathy with a highly variable clinical presentation, course, and outcome. The factors that determine the clinical variation of GBS are poorly understood which complicates the care and treatme
Autor:
Walgaard, Christa, Jacobs, Bart C., Lingsma, Hester F., Steyerberg, Ewout W., Cornblath, David R., van Doorn, Pieter A., de Wit, M. C. Y., van den Berg, B., Doets, A. Y., Leonhard, S. E., Verboon, J. C., van Woerkom, M., Tio-Gillen, A. P., van Rijs, W., Huizinga, H., Badrising, U. A., Bienfait, H. M. E., Blom, R. J., van Boheemen, C. J. M., Breukelman, A. J., Bronner, I. M., Dieks, H. J. G., van Dijk, G. W., van Engelen, B. G. M., Faber, C. G., Feenstra, B., Fokke, C., Garssen, M. P. J., Gijsbers, C. J., Gilhuis, H. J., van der Graaff, M. M., Groen, R. J., Hoogendoorn, T. A., Hovestad, A., Jansen, P. J. H. W., Jellema, K., Keuter, E., Kleyweg, R. P., van Koningsveld, R., van der Kooi, A. J., van der Kooi, E. L., Krudde, J., Kuks, J. B. M., Kuitwaard, K., Linssen, W. H. J. P., Lion, J., Lovenich, H., Manschot, S. M., Mellema, S. J., Merkies, I. S. J., van der Meulen, M. F. G., van der Meulen, W. D. M., Molenaar, D. S. M., Oenema, D. G., van Oosten, B. W., van Oostrom, J. C. H., van Orshoven, N. P., van der Ploeg, R. J. O., van der Pol, W. L., Polman, S., van der Ree, T. C., de Rijk, M. C., Ruitenberg, A., Ruts, L., Samijn, J. P. A., Schyns-Soeterboek, A. J. G. M., Stevens, M., Vermeij, F. H., Verschuuren, J. J. G. M., Visser, L. H., Wirtz, P. W., Wohlgemuth, M., Zwetsloot, C. P., Dippel, D. W. J., Hintzen, R. Q.
Publikováno v:
Journal of the Peripheral Nervous System
Journal of the Peripheral Nervous System, 23(4), 210-215. Wiley-Blackwell
Journal of the Peripheral Nervous System, 23, 4, pp. 210-215
Journal of the peripheral nervous system, 23(4), 210-215. Wiley-Blackwell
Journal of the Peripheral Nervous System, 23(4), 210-215
Journal of the Peripheral Nervous System, 23(4), 210-215. Wiley-Blackwell Publishing Ltd
Journal of the Peripheral Nervous System, 23, 210-215
the Dutch GBS Study Group 2018, ' Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial ', Journal of the Peripheral Nervous System, vol. 23, no. 4, pp. 210-215 . https://doi.org/10.1111/jns.12286
Journal of the Peripheral Nervous System, 23(4), 210-215. Wiley-Blackwell
Journal of the Peripheral Nervous System, 23, 4, pp. 210-215
Journal of the peripheral nervous system, 23(4), 210-215. Wiley-Blackwell
Journal of the Peripheral Nervous System, 23(4), 210-215
Journal of the Peripheral Nervous System, 23(4), 210-215. Wiley-Blackwell Publishing Ltd
Journal of the Peripheral Nervous System, 23, 210-215
the Dutch GBS Study Group 2018, ' Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial ', Journal of the Peripheral Nervous System, vol. 23, no. 4, pp. 210-215 . https://doi.org/10.1111/jns.12286
One course of intravenous immunoglobulins (IVIg) of 2 g/kg is standard treatment in Guillain-Barré syndrome (GBS) patients unable to walk independently. Despite treatment some patients recover poorly, in part related to rapid consumption of IVIg, in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3df239f086b25e3d2d61e736367a97b4
https://doi.org/10.1111/jns.12286
https://doi.org/10.1111/jns.12286